Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 71615 [2013-28621]

Download as PDF Federal Register / Vol. 78, No. 230 / Friday, November 29, 2013 / Notices proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. C. Annual Reporting Burden Respondents: 10,000. Responses per Respondent: 1. Total annual responses: 10,000. Hours per Response: .25. Total Burden Hours: 2,500. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat (MVCB), 1800 F Street NW., 2nd Floor, Washington, DC 20405–0001, telephone 202–501–4755. Please cite OMB Control No. 3090– 00XX, MyUSA, in all correspondence. Dated: November 25, 2013. Casey Coleman, Chief Information Officer. [FR Doc. 2013–28715 Filed 11–27–13; 8:45 am] BILLING CODE 6820–34–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Meeting of the Presidential Commission for the Study of Bioethical Issues Presidential Commission for the Study of Bioethical Issues, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: The Presidential Commission for the Study of Bioethical Issues (the Commission) will conduct its fifteenth meeting on December 18, 2013. At this meeting, the Commission will discuss the BRAIN Initiative and ongoing work in neuroscience. DATES: The meeting will take place Wednesday, December 18, 2013, from 9:00 a.m. to approximately 5:15 p.m. ADDRESSES: The Hamilton Crowne Plaza Hotel, 1001 14th Street NW., Washington, DC 20005. Telephone (202) 682–0111. FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications Director, Presidential Commission for sroberts on DSK5SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:56 Nov 27, 2013 Jkt 232001 the Study of Bioethical Issues, 1425 New York Avenue NW, Suite C–100, Washington, DC 20005. Telephone: 202–233–3960. Email: Hillary.Viers@ bioethics.gov. Additional information may be obtained at www.bioethics.gov. SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee Act of 1972, Public Law 92–463, 5 U.S.C. app. 2, notice is hereby given of the fifteenth meeting of the Commission. The meeting will be open to the public with attendance limited to space available. The meeting will also be webcast at www.bioethics.gov. Under authority of Executive Order 13521, dated November 24, 2009, the President established the Commission. The Commission is an expert panel of not more than 13 members who are drawn from the fields of bioethics, science, medicine, technology, engineering, law, philosophy, theology, or other areas of the humanities or social sciences. The Commission advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. The Commission seeks to identify and promote policies and practices that ensure scientific research, health care delivery, and technological innovation are conducted in a socially and ethically responsible manner. The main agenda item for the Commission’s fifteenth meeting is to discuss the BRAIN Initiative and ongoing work in neuroscience. The draft meeting agenda and other information about the Commission, including information about access to the webcast, will be available at www.bioethics.gov. The Commission welcomes input from anyone wishing to provide public comment on any issue before it. Respectful debate of opposing views and active participation by citizens in public exchange of ideas enhances overall public understanding of the issues at hand and conclusions reached by the Commission. The Commission is particularly interested in receiving comments and questions during the meeting that are responsive to specific sessions. Written comments will be accepted at the registration desk and comment forms will be provided to members of the public in order to write down questions and comments for the Commission as they arise. To accommodate as many individuals as possible, the time for each question or comment may be limited. If the number of individuals wishing to pose a question or make a comment is greater than can reasonably be accommodated during the scheduled meeting, the PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 71615 Commission may make a random selection. Written comments will also be accepted in advance of the meeting and are especially welcome. Please address written comments by email to info@ bioethics.gov, or by mail to the following address: Public Commentary, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C–100, Washington, DC 20005. Comments will be publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted. Anyone planning to attend the meeting who needs special assistance, such as sign language interpretation or other reasonable accommodations, should notify Esther Yoo by telephone at (202) 233–3960, or email at Esther.Yoo@bioethics.gov in advance of the meeting. The Commission will make every effort to accommodate persons who need special assistance. Dated: November 12, 2013. Lisa M. Lee, Executive Director, Presidential Commission for the Study of Bioethical Issues. [FR Doc. 2013–28621 Filed 11–27–13; 8:45 am] BILLING CODE 4154–06–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30 Day–14–13AAH] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call (404) 639–7570 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project CDC Work@Health Program: Phase 2 Training and Technical Assistance Evaluation—New—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). E:\FR\FM\29NON1.SGM 29NON1

Agencies

[Federal Register Volume 78, Number 230 (Friday, November 29, 2013)]
[Notices]
[Page 71615]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-28621]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the Presidential Commission for the Study of 
Bioethical Issues

AGENCY: Presidential Commission for the Study of Bioethical Issues, 
Office of the Assistant Secretary for Health, Office of the Secretary, 
Department of Health and Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Presidential Commission for the Study of Bioethical Issues 
(the Commission) will conduct its fifteenth meeting on December 18, 
2013. At this meeting, the Commission will discuss the BRAIN Initiative 
and ongoing work in neuroscience.

DATES: The meeting will take place Wednesday, December 18, 2013, from 
9:00 a.m. to approximately 5:15 p.m.

ADDRESSES: The Hamilton Crowne Plaza Hotel, 1001 14th Street NW., 
Washington, DC 20005. Telephone (202) 682-0111.

FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications 
Director, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Avenue NW, Suite C-100, Washington, DC 20005. Telephone: 
202-233-3960. Email: Hillary.Viers@bioethics.gov. Additional 
information may be obtained at www.bioethics.gov.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given 
of the fifteenth meeting of the Commission. The meeting will be open to 
the public with attendance limited to space available. The meeting will 
also be webcast at www.bioethics.gov.
    Under authority of Executive Order 13521, dated November 24, 2009, 
the President established the Commission. The Commission is an expert 
panel of not more than 13 members who are drawn from the fields of 
bioethics, science, medicine, technology, engineering, law, philosophy, 
theology, or other areas of the humanities or social sciences. The 
Commission advises the President on bioethical issues arising from 
advances in biomedicine and related areas of science and technology. 
The Commission seeks to identify and promote policies and practices 
that ensure scientific research, health care delivery, and 
technological innovation are conducted in a socially and ethically 
responsible manner.
    The main agenda item for the Commission's fifteenth meeting is to 
discuss the BRAIN Initiative and ongoing work in neuroscience.
    The draft meeting agenda and other information about the 
Commission, including information about access to the webcast, will be 
available at www.bioethics.gov.
    The Commission welcomes input from anyone wishing to provide public 
comment on any issue before it. Respectful debate of opposing views and 
active participation by citizens in public exchange of ideas enhances 
overall public understanding of the issues at hand and conclusions 
reached by the Commission. The Commission is particularly interested in 
receiving comments and questions during the meeting that are responsive 
to specific sessions. Written comments will be accepted at the 
registration desk and comment forms will be provided to members of the 
public in order to write down questions and comments for the Commission 
as they arise. To accommodate as many individuals as possible, the time 
for each question or comment may be limited. If the number of 
individuals wishing to pose a question or make a comment is greater 
than can reasonably be accommodated during the scheduled meeting, the 
Commission may make a random selection.
    Written comments will also be accepted in advance of the meeting 
and are especially welcome. Please address written comments by email to 
info@bioethics.gov, or by mail to the following address: Public 
Commentary, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Comments 
will be publicly available, including any personally identifiable or 
confidential business information that they contain. Trade secrets 
should not be submitted.
    Anyone planning to attend the meeting who needs special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify Esther Yoo by telephone at (202) 233-
3960, or email at Esther.Yoo@bioethics.gov in advance of the meeting. 
The Commission will make every effort to accommodate persons who need 
special assistance.

    Dated: November 12, 2013.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical 
Issues.
[FR Doc. 2013-28621 Filed 11-27-13; 8:45 am]
BILLING CODE 4154-06-P